Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass balance of Clifutinib in healthy males
NCT07211165Phase 1Completed
- Sponsor
- Sunshine Lake Pharma
- Start
- Sep 2025
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of clifutinib in acute myeloid leukemia (AML), sponsored by Sunshine Lake Pharma. Primary endpoints: Area Under the Concentration-Time Curve from Time Zero to Infinity, Time to Maximum Plasma Concentration and 4 more. Started Sep 2025; status: completed.
02
Drugs
clifutinib
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT07211165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07211165.